Egide（0OJ4）株式概要Egide S.A.は、その子会社とともに、フランス、フランス国外のEEC、米国、カナダ、および国際的なマイクロエレクトロニクスおよび光学製品アプリケーション用の気密パッケージ・ソリューションの開発、製造、販売を行っている。 詳細0OJ4 ファンダメンタル分析スノーフレーク・スコア評価3/6将来の成長0/6過去の実績0/6財務の健全性2/6配当金0/6報酬当社が推定した公正価値より10.9%で取引されている リスク分析UK市場と比較して、過去 3 か月間の株価の変動が非常に大きい過去5年間で収益は年間39.9%減少しました。 最新の財務報告は6か月以上前のものである 意味のある時価総額がありません ( €22M )すべてのリスクチェックを見る0OJ4 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€1.0864.6% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-4m37m2016201920222025202620282031Revenue €36.0mEarnings €3.1mAdvancedSet Fair ValueView all narrativesEgide S.A. 競合他社Vianet GroupSymbol: AIM:VNETMarket cap: UK£18.2mLight Science Technologies HoldingsSymbol: AIM:LSTMarket cap: UK£22.8mNewmark SecuritySymbol: AIM:NWTMarket cap: UK£9.2mCroma Security Solutions GroupSymbol: AIM:CSSGMarket cap: UK£9.3m価格と性能株価の高値、安値、推移の概要Egide過去の株価現在の株価€1.0852週高値€1.6752週安値€0.38ベータ0.231ヶ月の変化3.04%3ヶ月変化12.22%1年変化125.83%3年間の変化5.03%5年間の変化n/aIPOからの変化-74.49%最新ニュースNew Risk • May 11New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (18% average weekly change). Earnings have declined by 40% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Market cap is less than US$100m (€21.6m market cap, or US$25.4m).Buy Or Sell Opportunity • Apr 24Now 24% undervaluedOver the last 90 days, the stock has risen 3.2% to €1.04. The fair value is estimated to be €1.38, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.3% over the last 3 years. Earnings per share has grown by 40%.Buy Or Sell Opportunity • Apr 08Now 23% undervalued after recent price dropOver the last 90 days, the stock has fallen 19% to €0.99. The fair value is estimated to be €1.28, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.3% over the last 3 years. Earnings per share has grown by 40%.Buy Or Sell Opportunity • Mar 23Now 25% undervalued after recent price dropOver the last 90 days, the stock has fallen 32% to €0.96. The fair value is estimated to be €1.27, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.3% over the last 3 years. Earnings per share has grown by 40%.お知らせ • Jan 26+ 1 more updateEgide S.A. to Report Fiscal Year 2025 Results on Apr 27, 2026Egide S.A. announced that they will report fiscal year 2025 results at 5:40 PM, Central European Standard Time on Apr 27, 2026お知らせ • Oct 22Egide S.A. Provides Earnings Guidance for the Second Half of 2025Egide S.A. provided earnings guidance for the second half of 2025. For the second half, the Group expects revenue to grow in the second half of 2025 (H2 2025), driven by: Egide SA: continued commercial recovery as experienced in H1, with an expansion of the customer base in the European and North American markets; Egide USA: continued growth momentum in high value-added segments; Santier: active search for new opportunities to offset the end of major contracts, but weak activity is expected to persist in H2.最新情報をもっと見るRecent updatesNew Risk • May 11New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (18% average weekly change). Earnings have declined by 40% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Market cap is less than US$100m (€21.6m market cap, or US$25.4m).Buy Or Sell Opportunity • Apr 24Now 24% undervaluedOver the last 90 days, the stock has risen 3.2% to €1.04. The fair value is estimated to be €1.38, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.3% over the last 3 years. Earnings per share has grown by 40%.Buy Or Sell Opportunity • Apr 08Now 23% undervalued after recent price dropOver the last 90 days, the stock has fallen 19% to €0.99. The fair value is estimated to be €1.28, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.3% over the last 3 years. Earnings per share has grown by 40%.Buy Or Sell Opportunity • Mar 23Now 25% undervalued after recent price dropOver the last 90 days, the stock has fallen 32% to €0.96. The fair value is estimated to be €1.27, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.3% over the last 3 years. Earnings per share has grown by 40%.お知らせ • Jan 26+ 1 more updateEgide S.A. to Report Fiscal Year 2025 Results on Apr 27, 2026Egide S.A. announced that they will report fiscal year 2025 results at 5:40 PM, Central European Standard Time on Apr 27, 2026お知らせ • Oct 22Egide S.A. Provides Earnings Guidance for the Second Half of 2025Egide S.A. provided earnings guidance for the second half of 2025. For the second half, the Group expects revenue to grow in the second half of 2025 (H2 2025), driven by: Egide SA: continued commercial recovery as experienced in H1, with an expansion of the customer base in the European and North American markets; Egide USA: continued growth momentum in high value-added segments; Santier: active search for new opportunities to offset the end of major contracts, but weak activity is expected to persist in H2.お知らせ • Aug 06Egide S.A., Annual General Meeting, Sep 10, 2025Egide S.A., Annual General Meeting, Sep 10, 2025. Location: site industriel du sactar, bollene Franceお知らせ • Jul 03Egide S.A. Announces CEO ChangesAfter four years at Egide S.A. announced David HIEN will leave the EGIDE Group and his position as CEO on July 31, 2025. The Board of Directors, meeting on July 1st, 2025, under the chairmanship of Philippe BENSUSSAN, announced the appointment of Ignace DUPON as Group CEO, effective August 1, 2025. This appointment is part of an operational and strategic continuity, with Ignace DUPON having held key positions within the Group for more than ten years and currently leading US operations as General Manager of Egide USA since 2023 and Santier since 2024. With a civil engineering degree in electronics and management from the University of Leuven (KUL), Ignace DUPON is known for his leadership, strategic vision, and ability to grow businesses in complex international markets. International executive with over 30 years' experience in the high-tech and industrial sectors, he has held key positions within the Egide Group since 2014: Sales Director for Europe and Asia, then in the U.S. as Purchasing Director and now as GM of the Cambridge and San Diego (MD) sites. At EGIDE, he has led major strategic transformations including a return to profitability, client portfolio diversification, industrial restructuring, and the development of strategic accounts. Prior to Egide, he held senior purchasing, commercial and business development roles at Keopsys, Highwave Optical Technologies, and Alcatel Optronics, where he built international teams and negotiated industrial partnerships.Buy Or Sell Opportunity • Jun 27Now 25% undervalued after recent price dropOver the last 90 days, the stock has fallen 26% to €0.52. The fair value is estimated to be €0.69, however this is not to be taken as a buy recommendation but rather should be used as a guide only.お知らせ • Jun 17Egide S.A. to Report Fiscal Year 2024 Final Results on Jun 30, 2025Egide S.A. announced that they will report fiscal year 2024 final results at 5:40 PM, Central European Standard Time on Jun 30, 2025Reported Earnings • May 04Full year 2024 earnings releasedFull year 2024 results: Revenue: €30.0m (down 18% from FY 2023). Net loss: €2.48m (loss narrowed 21% from FY 2023). Revenue is forecast to grow 8.2% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Electronic industry in the United Kingdom.New Risk • Apr 07New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €8.12m (US$8.87m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (25% average weekly change). Earnings have declined by 21% per year over the past 5 years. Market cap is less than US$10m (€8.12m market cap, or US$8.87m). Minor Risk Shareholders have been diluted in the past year (21% increase in shares outstanding).お知らせ • Mar 05+ 1 more updateEgide S.A. to Report First Half, 2025 Results on Oct 20, 2025Egide S.A. announced that they will report first half, 2025 results on Oct 20, 2025New Risk • Jan 16New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 47% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings have declined by 21% per year over the past 5 years. Shareholders have been substantially diluted in the past year (47% increase in shares outstanding). Market cap is less than US$10m (€8.43m market cap, or US$8.67m).お知らせ • Nov 12Egide S.A. has filed a Follow-on Equity Offering in the amount of €1.695104 million.Egide S.A. has filed a Follow-on Equity Offering in the amount of €1.695104 million. Security Name: Shares Security Type: Common Stock Securities Offered: 2,607,853 Price\Range: €0.65 Transaction Features: Subsequent Direct Listingお知らせ • Jun 19Egide S.A. to Report Fiscal Year 2023 Results on Jul 15, 2024Egide S.A. announced that they will report fiscal year 2023 results at 12:00 PM, Central European Standard Time on Jul 15, 2024お知らせ • Nov 23Egide S.A. has filed a Follow-on Equity Offering.Egide S.A. has filed a Follow-on Equity Offering. Security Name: Shares Security Type: Common Stock Transaction Features: Rights Offeringお知らせ • Sep 07Egide S.A. has completed a Follow-on Equity Offering in the amount of €1.921561 million.Egide S.A. has completed a Follow-on Equity Offering in the amount of €1.921561 million. Security Name: Shares Security Type: Common Stock Securities Offered: 2,956,248 Price\Range: €0.65 Transaction Features: Rights Offeringお知らせ • Sep 06Egide S.A. to Report First Half, 2023 Results on Oct 26, 2023Egide S.A. announced that they will report first half, 2023 results on Oct 26, 2023Board Change • Aug 18Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. Independent Director Michel Faure was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Jul 22Egide S.A. Provides Sales Guidance for the Second Half of 2023Egide S.A. provided sales guidance for the second half of 2023. Driven by strong sales momentum across all products in first half of 2023, the company intends to maintain a similar level of revenue in the second half of 2023.New Risk • Jul 14New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.2% Last year net profit margin: 4.5% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.9x net interest cover). Shares are highly illiquid. High level of non-cash earnings (35% accrual ratio). Market cap is less than US$10m (€6.58m market cap, or US$7.39m). Minor Risk Profit margins are more than 30% lower than last year (2.2% net profit margin).Board Change • Jul 14Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. Independent Director Michel Faure was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Jun 02+ 1 more updateEgide S.A. Announces Management ChangesThe Board of Directors of Egide Group, meeting on June 1, 2023, announced that it has accepted the resignation of Mr. Jim COLLINS as Chairman and Chief Executive Officer of the Group. Mr. Jim COLLINS remains an employee of Egide USA, as director of the US entities to be sold, and a member of the Board of Directors. The position of Chairman and Chief Executive Officer is now split between: the Chairman's position, which has been delegated to and accepted by Mr. Michel FAURE (Board member since 2016), the Group's CEO position is delegated to and accepted by Mr. Philippe BRINGUIER, which he will combine with his position as Chief Financial Officer; Mr. David HIEN, General Manager of the Bollène facility in France, is appointed Deputy CEO of Egide SA.お知らせ • May 05An unknown buyer signed a non-binding letter of intent to acquire Egide USA, Inc. from Egide S.A. (ENXTPA:ALGID).An unknown buyer signed a non-binding letter of intent to acquire Egide USA, Inc. from Egide S.A. (ENXTPA:ALGID) on May 3, 2023.Board Change • Apr 15Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 2 highly experienced directors. Independent Director Michel Faure was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Mar 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 2 highly experienced directors. Independent Director Michel Faure was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Apr 04Full year 2021 earnings releasedFull year 2021 results: Revenue: €32.5m (up 8.4% from FY 2020). Net income: €50.0k (down 95% from FY 2020). Profit margin: 0.2% (down from 3.3% in FY 2020). Over the next year, revenue is forecast to grow 12%, compared to a 8.2% growth forecast for the industry in the United Kingdom.Board Change • Mar 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Independent Director Michel Faure was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.株主還元0OJ4GB ElectronicGB 市場7D1.1%-0.9%-0.9%1Y125.8%54.5%20.0%株主還元を見る業界別リターン: 0OJ4過去 1 年間で54.5 % の収益を上げたUK Electronic業界を上回りました。リターン対市場: 0OJ4過去 1 年間で20 % の収益を上げたUK市場を上回りました。価格変動Is 0OJ4's price volatile compared to industry and market?0OJ4 volatility0OJ4 Average Weekly Movement18.0%Electronic Industry Average Movement5.9%Market Average Movement5.6%10% most volatile stocks in GB Market11.8%10% least volatile stocks in GB Market3.1%安定した株価: 0OJ4の株価は、 UK市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 0OJ4の weekly volatility ( 18% ) は過去 1 年間安定していますが、依然としてUKの株式の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト1986248Ignace Duponwww.egide-group.comEgide S.A.は、その子会社とともに、フランス、フランス以外のEEC、米国、カナダ、および国際的なマイクロエレクトロニクスおよび光学製品アプリケーション用の気密パッケージソリューションの開発、製造、販売を行っている。サーマルイメージング市場向けパッケージ、ウィンドウアセンブリ、高精度ウィンドウホルダ、高温同時焼成セラミック（HTCC）フィードスルー、ハーメチックハウジング、セラミック基板、ゲッター溶接、冷却IRシステム用コールドフィンガー、パワーパッケージの設計・製造を行っている。また、光電子チップの保護と相互接続、さまざまな市場向けの各種RFパッケージ、RFおよびDCガラスビーズ、SMPMコネクタ、表面実装およびリードフレームを含むHTCCパッケージ、ボールグリッドアレイ、ランドグリッドアレイ、クワッドフラットノーリードおよびリードレスチップキャリア、ピングリッドアレイからなるリードレスパッケージ、HTTCコネクタ、HTCCセラミック基板も提供している。同社は防衛・宇宙、通信、産業・エネルギー、医療、オプトエレクトロニクス、赤外線、センサー、RF、通信などの市場に製品を供給している。Egide S.A.は1986年に設立され、フランスのボレーヌに本社を置いている。もっと見るEgide S.A. 基礎のまとめEgide の収益と売上を時価総額と比較するとどうか。0OJ4 基礎統計学時価総額€21.73m収益（TTM）-€2.97m売上高(TTM)€30.16m0.7xP/Sレシオ-7.3xPER（株価収益率0OJ4 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計0OJ4 損益計算書（TTM）収益€30.16m売上原価€10.97m売上総利益€19.19mその他の費用€22.16m収益-€2.97m直近の収益報告Jun 30, 2025次回決算日Jun 30, 2026一株当たり利益（EPS）-0.15グロス・マージン63.64%純利益率-9.85%有利子負債／自己資本比率187.2%0OJ4 の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/14 03:14終値2026/05/14 00:00収益2025/06/30年間収益2024/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Egide S.A. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Arnaud RiverainGreenSome Finance
New Risk • May 11New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (18% average weekly change). Earnings have declined by 40% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Market cap is less than US$100m (€21.6m market cap, or US$25.4m).
Buy Or Sell Opportunity • Apr 24Now 24% undervaluedOver the last 90 days, the stock has risen 3.2% to €1.04. The fair value is estimated to be €1.38, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.3% over the last 3 years. Earnings per share has grown by 40%.
Buy Or Sell Opportunity • Apr 08Now 23% undervalued after recent price dropOver the last 90 days, the stock has fallen 19% to €0.99. The fair value is estimated to be €1.28, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.3% over the last 3 years. Earnings per share has grown by 40%.
Buy Or Sell Opportunity • Mar 23Now 25% undervalued after recent price dropOver the last 90 days, the stock has fallen 32% to €0.96. The fair value is estimated to be €1.27, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.3% over the last 3 years. Earnings per share has grown by 40%.
お知らせ • Jan 26+ 1 more updateEgide S.A. to Report Fiscal Year 2025 Results on Apr 27, 2026Egide S.A. announced that they will report fiscal year 2025 results at 5:40 PM, Central European Standard Time on Apr 27, 2026
お知らせ • Oct 22Egide S.A. Provides Earnings Guidance for the Second Half of 2025Egide S.A. provided earnings guidance for the second half of 2025. For the second half, the Group expects revenue to grow in the second half of 2025 (H2 2025), driven by: Egide SA: continued commercial recovery as experienced in H1, with an expansion of the customer base in the European and North American markets; Egide USA: continued growth momentum in high value-added segments; Santier: active search for new opportunities to offset the end of major contracts, but weak activity is expected to persist in H2.
New Risk • May 11New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (18% average weekly change). Earnings have declined by 40% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Market cap is less than US$100m (€21.6m market cap, or US$25.4m).
Buy Or Sell Opportunity • Apr 24Now 24% undervaluedOver the last 90 days, the stock has risen 3.2% to €1.04. The fair value is estimated to be €1.38, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.3% over the last 3 years. Earnings per share has grown by 40%.
Buy Or Sell Opportunity • Apr 08Now 23% undervalued after recent price dropOver the last 90 days, the stock has fallen 19% to €0.99. The fair value is estimated to be €1.28, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.3% over the last 3 years. Earnings per share has grown by 40%.
Buy Or Sell Opportunity • Mar 23Now 25% undervalued after recent price dropOver the last 90 days, the stock has fallen 32% to €0.96. The fair value is estimated to be €1.27, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.3% over the last 3 years. Earnings per share has grown by 40%.
お知らせ • Jan 26+ 1 more updateEgide S.A. to Report Fiscal Year 2025 Results on Apr 27, 2026Egide S.A. announced that they will report fiscal year 2025 results at 5:40 PM, Central European Standard Time on Apr 27, 2026
お知らせ • Oct 22Egide S.A. Provides Earnings Guidance for the Second Half of 2025Egide S.A. provided earnings guidance for the second half of 2025. For the second half, the Group expects revenue to grow in the second half of 2025 (H2 2025), driven by: Egide SA: continued commercial recovery as experienced in H1, with an expansion of the customer base in the European and North American markets; Egide USA: continued growth momentum in high value-added segments; Santier: active search for new opportunities to offset the end of major contracts, but weak activity is expected to persist in H2.
お知らせ • Aug 06Egide S.A., Annual General Meeting, Sep 10, 2025Egide S.A., Annual General Meeting, Sep 10, 2025. Location: site industriel du sactar, bollene France
お知らせ • Jul 03Egide S.A. Announces CEO ChangesAfter four years at Egide S.A. announced David HIEN will leave the EGIDE Group and his position as CEO on July 31, 2025. The Board of Directors, meeting on July 1st, 2025, under the chairmanship of Philippe BENSUSSAN, announced the appointment of Ignace DUPON as Group CEO, effective August 1, 2025. This appointment is part of an operational and strategic continuity, with Ignace DUPON having held key positions within the Group for more than ten years and currently leading US operations as General Manager of Egide USA since 2023 and Santier since 2024. With a civil engineering degree in electronics and management from the University of Leuven (KUL), Ignace DUPON is known for his leadership, strategic vision, and ability to grow businesses in complex international markets. International executive with over 30 years' experience in the high-tech and industrial sectors, he has held key positions within the Egide Group since 2014: Sales Director for Europe and Asia, then in the U.S. as Purchasing Director and now as GM of the Cambridge and San Diego (MD) sites. At EGIDE, he has led major strategic transformations including a return to profitability, client portfolio diversification, industrial restructuring, and the development of strategic accounts. Prior to Egide, he held senior purchasing, commercial and business development roles at Keopsys, Highwave Optical Technologies, and Alcatel Optronics, where he built international teams and negotiated industrial partnerships.
Buy Or Sell Opportunity • Jun 27Now 25% undervalued after recent price dropOver the last 90 days, the stock has fallen 26% to €0.52. The fair value is estimated to be €0.69, however this is not to be taken as a buy recommendation but rather should be used as a guide only.
お知らせ • Jun 17Egide S.A. to Report Fiscal Year 2024 Final Results on Jun 30, 2025Egide S.A. announced that they will report fiscal year 2024 final results at 5:40 PM, Central European Standard Time on Jun 30, 2025
Reported Earnings • May 04Full year 2024 earnings releasedFull year 2024 results: Revenue: €30.0m (down 18% from FY 2023). Net loss: €2.48m (loss narrowed 21% from FY 2023). Revenue is forecast to grow 8.2% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Electronic industry in the United Kingdom.
New Risk • Apr 07New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €8.12m (US$8.87m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (25% average weekly change). Earnings have declined by 21% per year over the past 5 years. Market cap is less than US$10m (€8.12m market cap, or US$8.87m). Minor Risk Shareholders have been diluted in the past year (21% increase in shares outstanding).
お知らせ • Mar 05+ 1 more updateEgide S.A. to Report First Half, 2025 Results on Oct 20, 2025Egide S.A. announced that they will report first half, 2025 results on Oct 20, 2025
New Risk • Jan 16New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 47% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings have declined by 21% per year over the past 5 years. Shareholders have been substantially diluted in the past year (47% increase in shares outstanding). Market cap is less than US$10m (€8.43m market cap, or US$8.67m).
お知らせ • Nov 12Egide S.A. has filed a Follow-on Equity Offering in the amount of €1.695104 million.Egide S.A. has filed a Follow-on Equity Offering in the amount of €1.695104 million. Security Name: Shares Security Type: Common Stock Securities Offered: 2,607,853 Price\Range: €0.65 Transaction Features: Subsequent Direct Listing
お知らせ • Jun 19Egide S.A. to Report Fiscal Year 2023 Results on Jul 15, 2024Egide S.A. announced that they will report fiscal year 2023 results at 12:00 PM, Central European Standard Time on Jul 15, 2024
お知らせ • Nov 23Egide S.A. has filed a Follow-on Equity Offering.Egide S.A. has filed a Follow-on Equity Offering. Security Name: Shares Security Type: Common Stock Transaction Features: Rights Offering
お知らせ • Sep 07Egide S.A. has completed a Follow-on Equity Offering in the amount of €1.921561 million.Egide S.A. has completed a Follow-on Equity Offering in the amount of €1.921561 million. Security Name: Shares Security Type: Common Stock Securities Offered: 2,956,248 Price\Range: €0.65 Transaction Features: Rights Offering
お知らせ • Sep 06Egide S.A. to Report First Half, 2023 Results on Oct 26, 2023Egide S.A. announced that they will report first half, 2023 results on Oct 26, 2023
Board Change • Aug 18Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. Independent Director Michel Faure was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Jul 22Egide S.A. Provides Sales Guidance for the Second Half of 2023Egide S.A. provided sales guidance for the second half of 2023. Driven by strong sales momentum across all products in first half of 2023, the company intends to maintain a similar level of revenue in the second half of 2023.
New Risk • Jul 14New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.2% Last year net profit margin: 4.5% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.9x net interest cover). Shares are highly illiquid. High level of non-cash earnings (35% accrual ratio). Market cap is less than US$10m (€6.58m market cap, or US$7.39m). Minor Risk Profit margins are more than 30% lower than last year (2.2% net profit margin).
Board Change • Jul 14Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. Independent Director Michel Faure was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Jun 02+ 1 more updateEgide S.A. Announces Management ChangesThe Board of Directors of Egide Group, meeting on June 1, 2023, announced that it has accepted the resignation of Mr. Jim COLLINS as Chairman and Chief Executive Officer of the Group. Mr. Jim COLLINS remains an employee of Egide USA, as director of the US entities to be sold, and a member of the Board of Directors. The position of Chairman and Chief Executive Officer is now split between: the Chairman's position, which has been delegated to and accepted by Mr. Michel FAURE (Board member since 2016), the Group's CEO position is delegated to and accepted by Mr. Philippe BRINGUIER, which he will combine with his position as Chief Financial Officer; Mr. David HIEN, General Manager of the Bollène facility in France, is appointed Deputy CEO of Egide SA.
お知らせ • May 05An unknown buyer signed a non-binding letter of intent to acquire Egide USA, Inc. from Egide S.A. (ENXTPA:ALGID).An unknown buyer signed a non-binding letter of intent to acquire Egide USA, Inc. from Egide S.A. (ENXTPA:ALGID) on May 3, 2023.
Board Change • Apr 15Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 2 highly experienced directors. Independent Director Michel Faure was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Mar 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 2 highly experienced directors. Independent Director Michel Faure was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Apr 04Full year 2021 earnings releasedFull year 2021 results: Revenue: €32.5m (up 8.4% from FY 2020). Net income: €50.0k (down 95% from FY 2020). Profit margin: 0.2% (down from 3.3% in FY 2020). Over the next year, revenue is forecast to grow 12%, compared to a 8.2% growth forecast for the industry in the United Kingdom.
Board Change • Mar 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Independent Director Michel Faure was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
